2024 Spain Sexually-Transmitted Disease (STD) Market: Shares and Segment Forecasts-Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), Syphilis

August 2020 | 280 pages | ID: 20E8BA3CA5E4EN
Venture Planning Group

Abstracts

About This Report

This new 280-page report from LeadingMarketResearch.com presents detailed analysis of the Spanish STD market, including sales forecasts and supplier shares forChancroid,Chlamydia,Gonorrhea,Herpes(I/II, VI),Papillomavirus(Pap Smear, HPV), andSyphilis. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs.

The report is available by section, and can be customized to specific information needs and budget.

In addition to market share and sales forecasts, the report:

• Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;
• Reviews features and operating characteristics of major analyzers used for STD testing;
• Profiles key suppliers and potential market entrants developing innovative technologies and products; and
• Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.

Methodology

The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products.

The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products.

In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as VPGMarketResearch’s proprietary data files was conducted.

Contains 280 pages and 16 tables

Contents

I. INTRODUCTION

II. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Major Infectious Disease Tests
  1. Chancroid
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  2. Chlamydia
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  3. Gonorrhea
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  4. Herpes Simplex Virus
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
Human Herpes Virus-6 (HHV-6)
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  5. Papillomavirus (HPV)
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  6. Syphilis
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
B. Instrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
C. Emerging Diagnostic Technologies
  1. Molecular Diagnostics
  2. Monoclonal Antibodies
  3. Immunoassays
  4. Differential Light Scattering
  5. Information Technology
  6. Artificial Intelligence
  7. Liposomes
  8. Flow Cytometry
  9. Chromatography
  10. Diagnostic Imaging
  11. Gel Microdroplets
  12. Other

VII. SPAIN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. Marketing Approaches
  2. Product Complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types of Distributors
  7. Market Segmentation

POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

COMPETITIVE ASSESSMENTS

Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix/Erba
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
Hologic/Gen-Probe
ID Biomedical/GSK
Kreatech/Leica
Lonza
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac
Wako

List Of Tables

LIST OF TABLES

Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Pap Smear/HPV Tests
Major Companies Developing or Marketing Syphilis Tests
Spain
Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
Spain
Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
Spain
Chlamydia Diagnostics Sales by Major Supplier
Spain
Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
Spain
Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
Spain
Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
Spain
Herpes Testing Market Diagnostics Sales by Major Supplier
Spain
PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
Spain
Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
Spain
Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
Spain
Syphilis Testing Market Diagnostics Sales by Major Supplier